A new study on antibody production shows people who experienced mild illness from COVID-19, developed long-lasting antibody protection.
Most COVID-19 survivors may develop lasting protection if they become reinfected. In a study of 185 patients, including 41 who had been infected more than six months earlier, scientists at La Jolla Institute for Immunology in California found that immune…
One of the most significant questions about the novel coronavirus is whether people who are infected are immune from reinfection and, if so, for how long. To determine the answer, University of Arizona Health Sciences researchers studied the production of…